Vitrafy signs Hoxworth Blood Center to expand US cryopreservation footprint
Vitrafy Life Sciences (ASX: VFY) has partnered with Hoxworth Blood Center to configure its next-generation cryopreservation ecosystem for red blood cells, extending the Company’s footprint across the US blood network. Announced on 23 July 2026, the agreement builds on Vitrafy’s earlier partnership with Vitalant and responds to the looming end-of-life of legacy red blood cell freezing technology from 2027.
Founded in 1938, Hoxworth is described as the oldest operating blood bank in the United States, collecting ~1% of US blood units annually, operating 7 permanent collection sites, and serving over 31 hospitals. Investors should note the Company has stated the agreement “is not expected to generate revenue for the Company,” positioning this as a strategic, in-kind arrangement rather than a near-term income event.
When big ASX news breaks, our subscribers know first
Why the red blood cell preservation crisis matters
Cryopreservation is the process of preserving biological samples, retaining the integrity of sensitive biological materials throughout collection, storage, and delivery. For red blood cells, this capability underpins two critical functions: military stockpiles and civilian rare blood programs.
The core problem is the discontinuation of critical legacy freezing technology from 2027. According to Vitrafy, this end-of-life event leaves the industry without an established successor. Without a replacement, the blood system risks losing the preservation capability it depends on.
For investors, this frames a genuine, time-sensitive industry gap. Vitrafy has positioned its ecosystem as a next-generation solution to this emerging threat, with the US market identified as the Company’s priority.
The Vitrafy ecosystem explained
Vitrafy has developed a proprietary cryopreservation ecosystem designed to deliver a complete freezing and storage solution while maintaining the quality of sensitive biological samples throughout collection, storage, and delivery.
The ecosystem comprises two core components:
-
Guardion: the cryopreservation freezing unit.
-
Lifechain™: a cloud-based software platform integrating with the freezing hardware.
Inside the Hoxworth partnership
Under the partnership, Vitrafy and Hoxworth will “each contribute resources and in-kind support” toward delivering a solution to the emerging preservation threat. As noted, the agreement “is not expected to generate revenue” for the Company.
Vitrafy will initially place one cryopreservation freezing and software package at Hoxworth during 1H FY27. The Company expects this to support broader engagement with market participants and government stakeholders toward a unified industry response to the red blood cell preservation issue.
The Vitalant cryopreservation partnership, announced in June 2026, placed two Guardion units at the Vitalant Innovation Center in Denver and gave Vitrafy direct access to a blood network serving over 900 hospitals, establishing the template that the Hoxworth arrangement now builds on.
The Company’s stated goal is to convert the arrangement into a “longer-term commercial engagement across a wide range of blood centers,” using the Hoxworth relationship as a stepping stone toward broader industry adoption.
| Metric | Detail |
|---|---|
| Partner | Hoxworth Blood Center (est. 1938) |
| US blood collected | ~1% annually |
| Hospitals served | 31 across 18 counties |
| Collection sites | 7 + mobile network |
| Initial deployment | One freezing + software package, 1H FY27 |
| Revenue expected | None (in-kind partnership) |
CEO Commentary
“We are really excited to partner with Hoxworth Blood Center, one of the oldest and most respected blood centers in the USA, to actively address an issue of national significance. Building on our recently announced partnership with Vitalant, the continued recognition of Vitrafy’s cryopreservation ecosystem as the next generation solution to this crisis reinforces our belief that we are securing meaningful market traction and creating a pathway to significant commercial scale,” said Brent Owens, Managing Director and Chief Executive Officer.
About Hoxworth Blood Center
Hoxworth Blood Center, University of Cincinnati, brings established credibility to Vitrafy’s US expansion strategy. Key details include:
-
Oldest operating blood bank in the United States, founded in 1938.
-
Part of the University of Cincinnati, an academic centre combining research and clinical expertise.
-
Serves 31 hospitals across 18 counties in Southwestern Ohio, Northern Kentucky, and Southeastern Indiana.
-
Operates 7 collection centres alongside a mobile blood drive network across the Greater Cincinnati region.
A respected, well-connected partner strengthens Vitrafy’s credibility as it works to scale its ecosystem across the US network.
What this means for investors and what comes next
The Hoxworth agreement reflects Vitrafy’s strategy of building an industry-wide, collaborative footprint ahead of the 2027 legacy technology gap. Combined with its earlier Vitalant partnership, the Company is assembling multiple US blood network relationships as it positions its ecosystem as a next-generation response.
The Company expects the partnership to support broader engagement with market participants and government stakeholders toward a unified industry response to the red blood cell preservation issue. The stated pathway is to convert these arrangements into longer-term commercial engagements across a wide range of blood centres.
The US Army platelet study, which recorded 94% mean post-thaw recovery using Vitrafy’s no-wash protocol, represents the clinical validation underpinning the government stakeholder engagement the Company is now pursuing alongside its civilian blood network partnerships.
Investors should weigh this against the transparency of the terms. This specific agreement is non-revenue and in-kind, meaning its value lies in strategic positioning and potential future commercial conversion rather than near-term income.
For now, the accumulation of US partnerships signals growing market traction as Vitrafy works to establish its cryopreservation ecosystem across the American blood network.
Don’t Miss the Next Healthcare Breakthrough on ASX
Big News Blast delivers FREE breaking ASX healthcare news directly to your inbox within minutes of release, complete with in-depth analysis. Join 20,000+ subscribers already staying ahead of the market. Click the “Free Alerts” button at StockWire X to get the next market-moving announcement the moment it drops.